Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

Clinical trial NCT05897294 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT05897294
Sponsor: TFF Pharmaceuticals, Inc.
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Invasive Pulmonary Aspergillosis Allergic Bronchopulmonary Aspergillosis Chronic Pulmonary Aspergillosis Aspergillus Tracheobronchitis Anastomotic Infection Pulmonary Fungal Infection

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.